-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pear Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q4 2022.
- Pear Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$29.2M, a 14.8% increase year-over-year.
- Pear Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$123M, a 16.7% decline year-over-year.
- Pear Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$123M, a 16.7% decline from 2021.
- Pear Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$106M, a 37.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)